血清微小核糖核酸-1-3p、微小核糖核酸-155水平与老年2型糖尿病肾病患者并发肌少症的风险预测研究
CSTR:
作者:
作者单位:

(秦皇岛市第一医院肾内科,河北 秦皇岛 066000)

作者简介:

通讯作者:

中图分类号:

基金项目:

秦皇岛市科学技术研究与发展项目(202401A061)


Correlation between serum miR-1-3p and miR-155 levels and sarcopenia in elderly patients with type 2 diabetic nephropathy and construction of a prediction model
Author:
Affiliation:

(Department of Nephrology, Qinhuangdao First Hospital, Qinhuangdao 066000, Hebei Province, China)

Fund Project:

This work was supported by the Project of Qinhuangdao Science and Technology Research and Development(202401AO61).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探究血清微小核糖核酸-1-3p(miR-1-3p)、微小核糖核酸-155(miR-155)水平与老年2型糖尿病肾病(T2DN)患者并发肌少症的关系,并构建预测模型。方法 回顾性分析2024年3月至2025年5月秦皇岛市第一医院收治的192例老年T2DN患者的临床资料。依据是否并发肌少症分为肌少症组(n=64)和非肌少症组(n=128)。对比两组患者临床资料,血清miR-1-3p和miR-155水平。采用logistic回归分析评估影响老年T2DN患者并发肌少症的危险因素。构建风险预测模型,并绘制受试者工作特征曲线评估模型的预测效能。采用SPSS 27.0软件和R软件(4.0.2)进行数据分析。根据数据类型,组间比较分别采用t检验、χ2检验及Fisher精确检验。结果 肌少症组年龄≥70岁占比、稳态模型评估胰岛素抵抗指数(HOMA-IR)水平高于非肌少症组(P<0.05),骨密度、25-羧基维生素D、骨骼肌质量指数、握力、步速、简易体能状况量表评分及miR-155、miR-1-3p水平低于非肌少症组(P<0.05)。Logistic回归分析结果显示,骨密度、HOMA-IR、25-羧基维生素D、miR-1-3p及miR-155均与老年T2DN患者并发肌少症显著相关(P<0.05)。基于多因素分析构建列线图模型。Hosmer-Lemeshow检验显示模型拟合优度良好(χ2=4.447,P=0.815),校准曲线显示预测概率与实际观察概率高度一致。该模型预测老年T2DN患者并发肌少症的曲线下面积(AUC)为0.970(95%CI 0.951~0.990),Bootstrap内部验证后校正AUC为0.963(95%CI 0.903~0.967)。决策曲线分析显示,在较宽阈值概率范围内,该模型具有良好的临床净获益。结论 基于miR-1-3p及miR-155构建的列线图模型对老年T2DN患者并发肌少症的预测效能较高,可为并发肌少症提供可靠的决策工具。

    Abstract:

    Objective To explore the relationship between serum microRNA-1-3p (miR-1-3p) and microRNA-155 (miR-155) levels and sarcopenia in elderly patients with type 2 diabetic nephropathy (T2DN), and the construction of prediction model. Methods A retrospective analysis was conducted on the clinical data of 192 elderly patients with T2DN admitted to our hospital from March 2024 to May 2025. The patients were divided into a sarcopenia group (n=64) and a non-sarcopenia group (n=128) based on the presence of sarcopenia. Clinical data and serum miR-1-3p and miR-155 levels were compared between the 2 groups. Logistic regression analysis was used to identify the risk factors for sarcopenia in elderly T2DN patients. A risk prediction model was constructed, and receiver operating characteristic (ROC) curve was plotted to evaluate the predictive performance of the model. SPSS statistics 27.0 and R (version 4.0.2) were employed for statistical analysis. Between-group comparison was performed using t test, χ2 test or Fisher′s exact test depending on data type. Results The sarcopenia group exhibited significantly larger proportion of aged ≥70 years and higher homeostatic model assessment of insulin resistance (HOMA-IR) levels, but lower bone mineral density, 25-hydroxyvitamin D, skeletal muscle mass index, grip strength, walking speed, Short Physical Performance Battery score, and serum miR-155 and miR-1-3p levels than in the non-sarcopenia group (P<0.05). Logistic regression analysis revealed that bone mineral density, HOMA-IR, 25-hydroxyvitamin D, miR-1-3p, and miR-155 were significantly associated with sarcopenia in elderly patients with T2DN (P<0.05). A nomogram model was constructed based on the results of multivariate analysis. Hosmer-Lemeshow test indicated sound goodness of fit of the model (χ2=4.447, P=0.815), and calibration curve analysis showed high consistency between the predicted and observed probabilities. ROC curve analysis demonstrated that the model yielded an area under the curve (AUC) of 0.970 (95%CI 0.951-0.990) for predicting sarcopenia in elderly T2DN patients, with a corrected AUC of 0.963 (95%CI 0.903-0.967) after Bootstrap internal validation. Decision curve analysis showed favorable clinical net benefit across a wide range of threshold probabilities. Conclusion The nomogram model constructed based on miR-1-3p and miR-155 demonstrates high predictive efficacy for sarcopenia in elderly patients with T2DN, providing a reliable decision-making tool for sarcopenia prediction.

    参考文献
    相似文献
    引证文献
引用本文

朱娜,刘维萍,邵雪,毛明华.血清微小核糖核酸-1-3p、微小核糖核酸-155水平与老年2型糖尿病肾病患者并发肌少症的风险预测研究[J].中华老年多器官疾病杂志,2026,25(10):773-778
DOI:10.11915/j. issn.1671-5403.2026.10.153

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-10-16
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-11-11
  • 出版日期:
文章二维码